According to MarketBeat, Syneos Health currently has an average rating of “Hold” and an average price target of $53.

Source: https://www.etfdailynews.com/2023/02/05/barclays-plc-cuts-stock-position-in-syneos-health-inc-nasdaqsynh/

Assetmark Inc. grew its holdings in shares of Syneos Health, Inc. () by 20.1% during the third quarter, reports.

Source: https://www.etfdailynews.com/2023/01/22/assetmark-inc-raises-stock-position-in-syneos-health-inc-nasdaqsynh/

Barclays upgraded shares of Syneos Health from an “underweight” rating to an “equal weight” rating in a research note on Wednesday, May 10th.

Source: https://www.americanbankingnews.com/2023/06/17/20647-shares-in-syneos-health-inc-nasdaqsynh-bought-by-etf-managers-group-llc.html

Clearbridge Investments LLC grew its position in shares of Syneos Health by 5.6% during the second quarter.

Source: https://www.etfdailynews.com/2023/02/05/barclays-plc-cuts-stock-position-in-syneos-health-inc-nasdaqsynh-2/

Finally, Guggenheim downgraded shares of Syneos Health from a “buy” rating to a “neutral” rating in a research note on Wednesday, September 14th.

Source: https://www.americanbankingnews.com/2023/01/03/artemis-investment-management-llp-trims-stock-holdings-in-syneos-health-inc-nasdaqsynh.html

Finally, JPMorgan Chase & Co. cut Syneos Health from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $85.00 to $53.00 in a research report on Tuesday, October 18th.

Source: https://www.americanbankingnews.com/2023/01/07/assenagon-asset-management-s-a-increases-stock-holdings-in-syneos-health-inc-nasdaqsynh.html

Rong Yang, CEO of Fosun Pharma USA and Senior Vice President of Fosun Pharma agreed, “As Fosun Pharma is expanding its innovative medicine presence in the US we are happy to work with industry leader Syneos Health as our strategic partner.

Source: https://forextv.com/top-news/syneos-health-announces-partnership-with-fosun-pharma-usa-to-launch-serplulimab/

Sell-side analysts anticipate that Syneos Health, Inc. will post 2.85 EPS for the current fiscal year.

Source: https://www.etfdailynews.com/2023/04/09/fifth-third-bancorp-buys-1125-shares-of-syneos-health-inc-nasdaqsynh/

State of Michigan Retirement System lifted its position in Syneos Health by 1.2% in the fourth quarter.

Source: https://www.etfdailynews.com/2023/06/22/5682-shares-in-syneos-health-inc-nasdaqsynh-acquired-by-fulton-bank-n-a/